Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials

Sidi Wang, Kelley Kidwell, Bo Huang +1

Overall survival (OS) is the gold standard for assessing patient benefit and cost-effectiveness of new cancer drugs. However, it is often difficult to use OS as the primary endpoin…